Miguel A. Ayala M.

Director General De Operaciones @ Landsteiner Scientific

About Miguel A. Ayala M.

Miguel A. Ayala M. serves as the Director General de Operaciones at Landsteiner Scientific, where he has worked since 2016. He has extensive experience in the pharmaceutical industry, having held various leadership roles at notable companies such as Takeda Pharmaceuticals, GSK, and Bayer.

Current Role at Landsteiner Scientific

Miguel A. Ayala M. serves as the Director General de Operaciones at Landsteiner Scientific since 2016. In this role, he is responsible for managing the Quality Management System and overseeing infrastructure projects at the pharmaceutical plants. He leads engineering and maintenance efforts to ensure optimal plant operations and product quality. His oversight includes the operations of two pharmaceutical plants that specialize in the production of a diverse range of products, including solids, immunosuppressants, semi-solids, parenterals, and lyophilized biotechnological products.

Previous Experience in Pharmaceuticals

Miguel A. Ayala M. has extensive experience in the pharmaceutical industry. He worked at Takeda Pharmaceuticals as Vicepresidente Regional de Operaciones para Latinoamérica from 2007 to 2011 and again from 2011 to 2014, totaling seven years in this role. Prior to that, he held positions at GSK as Gerente de Planta from 1994 to 1998, Aventis Pharmaceutical as Coordinador Aseguramiento de Calidad from 1987 to 1989, and Abbott as Químico Jr. / Químico Sr. Asist. Técnico Fermentación from 1986 to 1987. He also worked at Bayer as Jefe Area de Inyectables, Sólidos, Semisólidos y Líquidos from 1989 to 1994.

Education and Professional Development

Miguel A. Ayala M. holds a Maestría in Administración de Empresas from Universidad Autónoma del Estado de Morelos, which he completed from 1987 to 1990. He earned a Licenciatura in Químico Farmacéutico Biólogo from Universidad Nacional Autónoma de México from 1982 to 1986. Additionally, he is currently pursuing a Diplomado en Dirección Farmacéutica at Tecnológico de Monterrey, which he began in 2016.

People similar to Miguel A. Ayala M.